Реферат: Развитие антимикробной химиотерапии и новые парадигмы

LabroM.T. Antibacterial agents – phagocytes: new concepts for old in immunomodulation. Int JAntimicrob Agent 1998; 10:11-21.

MikasaK. SawakiM., KitaE., et al. Significant survival benefit of clarithromycin threatment for patients with unrespectable lung cancer. Proceedings of the 4th International conference on the macrolides, azalides, streptogramins and ketolides. Barcelona, Spain; 1998. 40, 4.05.

LabroM.T. Experimental evaluation of antibiotics as immunomodulators. JChemother 1994; 6 (Suppl.5):10-4.

ЕгоровА.М., СазыкинЮ.О. Антимикробные агенты в будущем. Вклад геномики в их создание. Антибиотики и химиотер 1999; 44(12):5-14.

MoirD.T. , ShawK.J., HareR.S., VovisG.F. Gemomics and antimicrobial drug discovery. Antimicrob Agent Chemother 1999; 43:439-46.

HeithottD.M., ConnerC.P., HannaP.C., etal. Simultaneous identification of bacteral virulence genes by invivo gene expression, PNAS USA 1997; 94:934-9.

MahanM.T., TobiasT.W., StauchT.M. Antibiotic – based selection of the bacterial genes that are specifically induced during infection of a host. PNAS USA 1995; 92:669-73.

CordwellS., NoawensA., VerrillsN., et al. The microbial proteome database – an automated laboratory. Catalogue for monitoring protein expression in bacteria. Electrophoresis 1999; 20:3580-8.

MannM. Quantitative proteomics? Nat Biotechnol 1999; 17:954-5.

WashburnM.P., YatesJ.R. Analysis of the microbial proteome. Current Opinion Microbiol 2000; 3:292-7.

LorenzM.G., WackernagelW. Bacterial genes transfer by natural genetic transformation in the environment. Microbiol Rev 1994; 61:627-32.

DaviesJ. Antibiotic resistance in mycobacteria In: Genetics and tuberculosis. John Wiley and Sons; 1998. р.195-205.

AbrahamE.P. Reflections on the development of the cephalosporins. Giorn Ital Chimioter 1970; 17:4-12.

Hamilton-MillerJ.M.T. Sir Edward Abraham’s contribution to the development of the cephalosporins: a reassessment. Int JAntimicrob Agent 2000; 15:179-84.